{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:59:29Z","timestamp":1783141169646,"version":"3.54.6"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Numerous consensus documents worldwide address luteinizing hormone (LH) supplementation in controlled ovarian stimulation, yet to the best of our knowledge, only one consensus paper has been published in the Arab region. This study presents a Delphi consensus by seven Iranian infertility experts, offering real-world clinical perspectives. The aim was to develop evidence-based opinions on LH's role alongside FSH in various aspects of assisted reproductive technology (ART), including LH levels, monitoring, r-hLH use, and suggested activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Employing the Delphi consensus approach, the Iran consensus unfolded in three steps. In Step 1, eight out of 10 statements gained approval, while two unclear statements were removed. In Step 2, the 20-member extended panel voted on the remaining eight statements.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Only one (statement 3) lacked consensus (55% agreement), prompting a modification. The revised statement (noted as statement 3\u2032) obtained an 83% agreement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The clinical perspectives included in this consensus complement clinical guidelines and policies that help further improve treatment outcomes, especially for patients with FSH and LH deficiencies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frph.2024.1397446","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:51:28Z","timestamp":1715230288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus"],"prefix":"10.3389","volume":"6","author":[{"given":"Saghar","family":"Salehpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Aleyasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Moini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezhat","family":"Mousavifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasresfahani","family":"Mohammadhossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedighe","family":"Abdollahi Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanuiefarimani","family":"Marzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1126\/science.1174130","article-title":"Development. Ovulation signals","volume":"324","author":"Duggavathi","year":"2009","journal-title":"Science"},{"key":"B2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-323-47912-7.00007-X","article-title":"Chapter 7\u2014neuroendocrine control of the menstrual cycle","volume-title":"Yen and Jaffe\u2019s Reproductive Endocrinology","author":"Hall","year":"2019"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00404-019-05346-y","article-title":"Endometrial expression of receptivity markers subject to ovulation induction agents","volume":"300","author":"Freis","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/humrep\/deab065","article-title":"Reduced FSH and LH action: implications for medically assisted reproduction","volume":"36","author":"Bosch","year":"2021","journal-title":"Hum Reprod"},{"key":"B5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1210\/er.2018-00065","article-title":"Two hormones for one receptor: evolution, biochemistry, actions, and pathophysiology of LH and hCG","volume":"39","author":"Casarini","year":"2018","journal-title":"Endocr Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/03007995.2017.1417827","article-title":"Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence?","volume":"34","author":"Younis","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"797365","DOI":"10.3389\/fendo.2021.797365","article-title":"Effect of genetic variants of gonadotropins and their receptors on ovarian stimulation outcomes: a delphi consensus","volume":"12","author":"Conforti","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rbmo.2015.03.001","article-title":"Altered amphiregulin expression induced by diverse luteinizing hormone receptor reactivity in granulosa cells affects IVF outcomes","volume":"30","author":"Huang","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bpobgyn.2017.04.002","article-title":"Genetics of gonadotropins and their receptors as markers of ovarian reserve and response in controlled ovarian stimulation","volume":"44","author":"Riccetti","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJM197410242911701","article-title":"Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern","volume":"291","author":"Boyar","year":"1974","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMcp0912024","article-title":"Clinical practice. Functional hypothalamic amenorrhea","volume":"363","author":"Gordon","year":"2010","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.bpobgyn.2012.05.004","article-title":"Management of anovulatory infertility","volume":"26","author":"Li","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0025-7125(16)31058-6","article-title":"Causes, evaluation, and management of athletic oligo-\/amenorrhea","volume":"69","author":"Shangold","year":"1985","journal-title":"Med Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/diacare.26.4.1016","article-title":"Menstrual cycle differences between women with type 1 diabetes and women without diabetes","volume":"26","author":"Strotmeyer","year":"2003","journal-title":"Diabetes Care"},{"key":"B15","volume-title":"Hypothalamic-Pituitary Diseases","author":"Tanriverdi","year":"2018"},{"key":"B16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.rbmo.2011.03.023","article-title":"Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective","volume":"23","author":"Wong","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"B17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF","volume":"12","author":"Tarlatzis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"B18","doi-asserted-by":"publisher","first-page":"675670","DOI":"10.3389\/fendo.2021.675670","article-title":"Optimising follicular development, pituitary suppression, triggering and luteal phase support during assisted reproductive technology: a delphi consensus","volume":"12","author":"Orvieto","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"555770","DOI":"10.19080\/GJORM.2023.09.555770","article-title":"Strategies to improve outcomes of ovulation induction and assisted reproductive technology (ART): the Iraqi consensus","volume":"9","author":"Al-Izzi","year":"2023","journal-title":"Glob J Reprod Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/ebnurs-2020-103303","article-title":"What are delphi studies?","volume":"23","author":"Barrett","year":"2020","journal-title":"Evid Based Nurs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12958-019-0460-4","article-title":"The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis","volume":"17","author":"Conforti","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12958-022-00888-4","article-title":"Is it necessary to monitor the serum luteinizing hormone (LH) concentration on the human chorionic gonadotropin (HCG) day among young women during the follicular-phase long protocol? A retrospective cohort study","volume":"20","author":"Zhang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.fertnstert.2011.06.061","article-title":"Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration","volume":"96","author":"Hugues","year":"2011","journal-title":"Fertil Steril"},{"key":"B25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10815-005-5998-8","article-title":"Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART","volume":"22","author":"Sonntag","year":"2005","journal-title":"J Assist Reprod Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1093\/humrep\/13.9.2612","article-title":"Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles","volume":"13","author":"Westergaard","year":"1998","journal-title":"Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review","volume":"109","author":"Alviggi","year":"2018","journal-title":"Fertil Steril"},{"key":"B28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1472-6483(10)61643-4","article-title":"Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study","volume":"8","author":"Humaidan","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"B29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1530\/eje.0.1340357","article-title":"Gonadotropins and gonadotropin receptors during the perimenopause","volume":"134","author":"Vihko","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1210\/jc.2007-1342","article-title":"Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men","volume":"92","author":"Wide","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1210\/jcem.80.4.7714119","article-title":"Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women","volume":"80","author":"Zumoff","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e46682","DOI":"10.1371\/journal.pone.0046682","article-title":"LH And hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling","volume":"7","author":"Casarini","year":"2012","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mce.2015.12.008","article-title":"Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro","volume":"422","author":"Casarini","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-016-0224-3","article-title":"Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse leydig cells in vitro","volume":"15","author":"Riccetti","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.jval.2018.04.447","article-title":"Delphi method: a qualitative approach for quantitative results","volume":"21","author":"Ng","year":"2018","journal-title":"Value Health"},{"key":"B36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/humrep\/16.8.1636","article-title":"Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH","volume":"16","author":"Balasch","year":"2001","journal-title":"Hum Reprod"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","article-title":"Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction","volume":"15","author":"Westergaard","year":"2000","journal-title":"Hum Reprod"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/humrep\/del219","article-title":"A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF\/ICSI cycles leads to lower live birth rates","volume":"21","author":"Lahoud","year":"2006","journal-title":"Hum Reprod"},{"key":"B41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/humrep\/deh601","article-title":"Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF\/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy","volume":"20","author":"Huirne","year":"2005","journal-title":"Hum Reprod"},{"key":"B42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4137\/CMRH.S17788","article-title":"Individualized treatment from theory to practice: the private case of adding LH during GnRH antagonist-based stimulation protocol","volume":"8","author":"Kol","year":"2014","journal-title":"Clin Med Insights Reprod Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/humrep\/den061","article-title":"Change, change, change: hormonal actions depend on changes in blood levels","volume":"23","author":"Kol","year":"2008","journal-title":"Hum Reprod"},{"key":"B44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-021-00759-4","article-title":"Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Conforti","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B45","article-title":"Hypogonadotropic hypogonadism (HH) and gonadotropin therapy","volume-title":"Endotext","author":"Hayes","year":"2000"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1210\/jc.2017-00131","article-title":"Functional hypothalamic amenorrhea: An Endocrine Society Clinical Practice Guideline","volume":"102","author":"Gordon","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.fertnstert.2010.10.021","article-title":"Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis","volume":"95","author":"Bosch","year":"2011","journal-title":"Fertil Steril"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.fertnstert.2012.01.130","article-title":"The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis","volume":"97","author":"Hill","year":"2012","journal-title":"Fertil Steril"},{"key":"B49","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.rbmo.2009.09.016","article-title":"Mid-follicular LH supplementation in women aged 35\u201339 years undergoing ICSI cycles: a randomized controlled study","volume":"19","author":"Matorras","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1748-1716.1960.tb01823.x","article-title":"Site of production of oestrogen in rat ovary as studied in micro-transplants","volume":"47","author":"Falck","year":"1959","journal-title":"Acta Physiol Scand Suppl"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/humrep\/17.8.2016","article-title":"Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation","volume":"17","author":"Humaidan","year":"2002","journal-title":"Hum Reprod"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/humrep\/15.7.1440","article-title":"Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH","volume":"15","author":"Fleming","year":"2000","journal-title":"Hum Reprod"},{"key":"B53","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/humupd\/dmy019","article-title":"Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis","volume":"24","author":"Alviggi","year":"2018","journal-title":"Hum Reprod Update"},{"key":"B54","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.fpc.0000167330.92786.5e","article-title":"Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation","volume":"15","author":"Behre","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1093\/humrep\/deac193","article-title":"The effect of polymorphisms in FSHR gene on late follicular phase progesterone and estradiol serum levels in predicted normoresponders","volume":"37","author":"Neves","year":"2022","journal-title":"Hum Reprod"},{"key":"B56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fendo.2019.00281","article-title":"Ovarian reserve markers to identify poor responders in the context of poseidon classification","volume":"10","author":"Grisendi","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/humrep\/deac246","article-title":"LH increases the response to FSH in granulosa-lutein cells from sub\/poor-responder patients in vitro","volume":"38","author":"Sperduti","year":"2023","journal-title":"Hum Reprod"},{"key":"B58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0015-0282(97)00501-3","article-title":"Clinical pharmacology of recombinant human luteinizing hormone: part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone","volume":"69","author":"le Cotonnec","year":"1998","journal-title":"Fertil Steril"},{"key":"B59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1472-6483(10)61927-X","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers","volume":"4","author":"Trinchard-Lugan","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"B60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1472-6483(10)61729-4","article-title":"Luteinizing hormone affects uterine receptivity independently of ovarian function","volume":"7","author":"Tesarik","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"B61","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1472-6483(10)61717-8","article-title":"Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation","volume":"6","author":"Herrler","year":"2003","journal-title":"Reprod Biomed Online"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2024.1397446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:51:31Z","timestamp":1715230291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2024.1397446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":61,"alternative-id":["10.3389\/frph.2024.1397446"],"URL":"https:\/\/doi.org\/10.3389\/frph.2024.1397446","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]},"article-number":"1397446"}}